Raju Mohan, Ventyx Biosciences CEO
September 20, 2021 07:36 AM EDTUpdated 11:27 AM
Financing

Months af­ter a mam­moth raise, Ven­tyx Bio­sciences dips back in­to ven­ture well

Nicole DeFeudis

Editor

Sev­er­al months af­ter emerg­ing from what CEO Ra­ju Mo­han called “qui­et mode” with a mam­moth $114 mil­lion raise, Ven­tyx Bio­sciences is now mak­ing its …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
ENDPOINTS CAREERS

Global Head of Marketing

Bachem

Bubendorf, BL, Switzerland

TRENDING NOW

Pfiz­er wants in on Sum­mit’s goal to beat Keytru­da via ADC com­bos

Post-Hoc: Phar­ma CEOs' al­ter­na­tive re­al­i­ty with Trump

Pfiz­er hires ex-FDA deputy Pa­trizia Cavaz­zoni as chief med­ical of­fi­cer

Sanofi, Te­va bol­ster case for IBD drug with Phase 2 da­ta, de­spite po­ten­tial com­pe­ti­tion

FDA ap­proves first drug to treat ul­tra-rare lipid stor­age dis­ease

sponsored

How AI can ad­dress on­go­ing chal­lenges in the life sci­ences in­dus­try

A service from the Financial Times